A major reason is Omicron has accumulated over 50 mutations, including about 30 in the spike protein, the part of the coronavirus that mRNA vaccines teach our immune systems to attack. . omicron: Omicron spreads faster and weakens jabs: WHO ... Pfizer and BioNTech Provide Update on Omicron Variant | Pfizer Novavax CEO on Covid Vaccine Approval, Omicron Efficacy ... The Center For Disease Control announced Monday afternoon, the omicron variant now makes up 73% of COVID-19 cases in the U.S. Boosters key to fighting omicron COVID-19 variant; a lot ... World Early Lab Test Shows Omicron Weakening Vaccine Effectiveness Shots should still help against severe disease with the variant on its way to dominate in Europe, scientists say Crude Drops 4% on Fears Over Vaccine Efficacy Against ... Johnson & Johnson to evaluate its COVID-19 vaccine against ... is the delta variant and we know that all the vaccines out there work well . Moderna's COVID-19 Vaccine Booster Shows Effectiveness ... Moderna vaccine no match for omicron except with booster ... Omicron variant has "robust ability" to evade COVID vaccines, but Pfizer says booster shots "neutralized" it Updated on: December 8, 2021 / 8:37 AM / CBS News Omicron more contagious but may be . Omicron Variant: Vaccine Efficacy Plunges Against ... Pfizer vaccine may be less effective against omicron ... Vaccine efficacy results in the coming weeks of keen . 4. Politicians and medical experts in Massachusetts are urging people to get vaccinated against COVID-19 amid growing concern over the omicron variant, but whether the vaccines protect against the new strain remains unclear. NEW BRUNSWICK, N.J., November 29, 2021Since the emergence of the COVID-19 pandemic, Johnson & Johnson (the Company) has been closely monitoring newly emerging COVID-19 variants.In collaboration with academic groups in South Africa and around the world, the Company has been evaluating the effectiveness of its COVID-19 vaccine across variants, including now the new and rapidly spreading Omicron . However, on Monday Moderna announced that a booster dose of its COVID-19 vaccine should offer protection against the rapidly spreading omicron variant. Omicron reduces vaccine efficacy, will outpace Delta variant, warns WHO Early evidence suggests Omicron causes "a reduction in vaccine efficacy against infection and transmission", the WHO said in . Stéphane Bancel, chief executive of the vaccine maker Moderna, has himself predicted that there will be a "material drop" in the effectiveness of vaccines against the omicron variant, due to the . Albert Bourla provides an update on the effectiveness of current vaccines against the Omicron variant, the debate over mandates and how new antiviral drugs will change the way we live with Covid . With the omicron variant spreading worldwide and at least one case confirmed in the U.S., officials and physicians said Mid-South residents should be cautious, but emphasized that people should . Centre's Omicron FAQ says mutations may lessen vaccine efficacy. With the Omicron variant now labeled a variant of concern, scientists are racing to test vaccines on their effectiveness. The energy sector is poised for a sharply lower start, pressured by steep declines across the underlying commodities and in . Federal officials confirmed the first case in the United States on Wednesday…. ___ Published. The Omicron variant of Covid-19 appears to spread faster than the Delta strain and preliminary findings suggest that it reduces the efficacy of vaccines, the World Health Organization said on Sunday. . Early research showed that it's effective against the omicron variant. In a press release Wednesday, Pfizer, Inc. and BioNTech SE announced a series of laboratory studies resulted in vaccine effectiveness against the highly transmissible Omicron variant after three . In the preliminary data, they found that the efficacy of the antibody response in plasma from people with two doses of the vaccine dropped 25-fold, but a third booster shot increased it 25-fold, back to levels seen after . The big question: Are current vaccines effective against the omicron . Moderna said it is working on an omicron-specific booster vaccine, along with testing a COVID-19 vaccine that could protect against several mutated strains of the coronavirus, in case a variant . Moderna said the following about the efficacy of the booster of its COVID-19 vaccine against the Omicron variant: A 37-fold rise in antibodies levels against Omicron was seen after the . There's been great concern about the new Omicron variant of SARS-CoV-2, the coronavirus that causes COVID-19. A two-shot course of Pfizer's vaccine has just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experiments. Indian vaccine makers are awaiting more data to understand the behaviour of the heavily mutated Omicron variant and have started assessing the efficacy of their vaccine, sources at Serum Institute of India, Bharat Biotech and Zydus Cadila told News18.com. The preliminary data about omicron and vaccines is coming in quickly and is revealing lower vaccine effectiveness. GENEVA: The Omicron coronavirus variant is more transmissible than the Delta strain and reduces vaccine efficacy but causes less severe symptoms according to early data, the World Health . A World Health Organization (WHO) official said on Wednesday . Novavax CEO on Covid Vaccine Approval, Omicron Efficacy December 21st, 2021, 5:10 PM GMT+0000 Novavax Inc.'s vaccine was cleared by European regulators on Monday, becoming the first Covid-19 . However, they are all waiting for "more data" from countries, which have detected the new strain. India's Covid-19 advisory group is hopeful that by next week NIV would be able to culture the virus and may know how the existing vaccines are working, the same people said. Prediction of waning COVID-19 vaccine efficacy against Omicron variant. Best estimates suggest vaccines are around 30%-40% effective at preventing infections and 70% effective at preventing severe disease.. A preprint study - one not formally reviewed by other scientists yet - that was conducted in Germany found . The Omicron variant could reduce the effectiveness of certain COVID-19 vaccines, according to new research. A Pfizer-BioNTech Covid-19 booster shot appears to provide strong protection against the omicron variant, while the initial two-dose vaccine may be insufficient to prevent infection, the companies . Studies of other COVID-19 vaccines from Moderna, AstraZeneca, and Johnson & Johnson are also underway. . Laboratory studies released this week suggest that the Omicron variant of the coronavirus will blunt the power of Pfizer and BioNTech's vaccine to prevent COVID-19 infection after two doses . By 0815 GMT, the pan . Nov. 26 (UPI) --Pharmaceutical companies announced plans Friday to test their COVID-19 vaccines' efficacy against the newly designated Omicron variant of the virus. The National Institute of Virology (NIV), Pune, which is in the process to isolate and culture the Omicron strain to assess the efficacy of vaccines may have some answers by next week, people in the know told ET. South Africa was the first country to report the Omicron variant to the WHO, but a Dutch health agency . The study found that Omicron lessened the Pfizer vaccine's protectiveness after two doses. The World Health Organization (WHO) on November 26 classified the COVID-19 Omicron variant—B.1.1.529—as a variant of concern (VOC). Dr. Mathai Mammen, global head of research and . Pfizer/BioNTech, AstraZeneca, and Johnson & Johnson have confirmed plans . European stocks fell more than 1% on Tuesday after vaccine-maker Moderna's head cast doubts over the efficacy of Covid-19 shots against the Omicron coronavirus variant. NEW BRUNSWICK, N.J., November 29, 2021Since the emergence of the COVID-19 pandemic, Johnson & Johnson (the Company) has been closely monitoring newly emerging COVID-19 variants.In collaboration with academic groups in South Africa and around the world, the Company has been evaluating the effectiveness of its COVID-19 vaccine across variants, including now the new and rapidly spreading Omicron . Vaccine manufacturers like Pfizer and Moderna have announced plans for a potential Omicron-specific shot. This decision was based on the evidence presented to the TAG-VE that Omicron has several mutations that may have an impact on how it behaves, for example, on how easily it spreads or the severity of illness it causes. Albert Bourla provides an update on the effectiveness of current vaccines against the Omicron variant, the debate over mandates and how new antiviral drugs will change the way we live with Covid . The WHO on Friday said that the actual risks of Omicron are not understood, but early evidence suggests an increased risk of reinfection compared with other highly transmissible variants. In a recent study posted to the medRxiv * preprint server, a team of researchers performed a meta-analysis of the results of . "A recently published small study addresses Sputnik vaccine's efficacy against omicron variant deliberately using serum samples that are not representative," the Russian center's statement . Researchers in Botswana and South Africa just detected the omicron variant a few weeks ago, but already many scientists are predicting that the efficacy of the vaccines will likely take a hit . Early analysis of UK Omicron and Delta cases showed the vaccines were less effective at stopping the new variant. Dr. Anthony Fauci on Sunday said "sobering" preliminary studies show the Omicron variant of COVID-19 appears to evade some of the protection provided by vaccines. "A recently published small study addresses Sputnik vaccine's efficacy against omicron variant deliberately using serum samples that are not representative," the Russian center's statement said. Nearly two years into the COVID-19 pandemic, the world raced Friday to contain a new coronavirus variant potentially more dangerous than the one that has fueled relentless waves of infection on every continent. BioNTech and Pfizer are the first manufacturers of a COVID vaccine to issue an official update on the efficacy of their shot against Omicron.The German and U.S. companies said two doses of their vaccine resulted in significantly lower neutralizing antibodies but a third dose boosted those antibodies by a factor of 25."We believe that T-cell responses induced by vaccination, particularly . COVID-19 vaccines will not be enough to withstand the Omicron variant, warned the CEO of BioNTech, the German company behind the mRNA vaccine produced with Pfizer. New data from a Canadian advisory panel shows a roughly 40-point drop in vaccines' ability to ward off a COVID infection just this month, as the omicron variant spreads Published December 20, 2021 . Vaccine Efficacy. The World Health Organization . Dec 11, 2021 10:30AM EST. The new COVID-19 variant, Omicron is more transmissible than the previous Delta strain and further reduces vaccine efficiency, stated the World Health Organisation (WHO) based on its early data. vaccine's efficacy against omicron variant . "A recently published small study addresses Sputnik vaccine's efficacy against omicron variant deliberately using serum samples that are not representative," the Russian center's statement said. Holiday plans, masks, vaccine efficacy: State epidemiologist discusses COVID-19 omicron variant | The Greenwood Commonwealth An analysis Tuesday of data from South Africa, where the new variant is driving a surge in . First detected in South Africa, the highly mutated variant has been found in 24 countries so far. Among those who had received two doses of the AstraZeneca vaccine, a Pfizer-BioNTech booster increased vaccine effectiveness against the omicron variant to 71.4% two weeks after it was received . The study, published in the British Medical Journal, doesn't say anything about the Moderna vaccine's efficacy against the Omicron variant, and it has no details on what protection people may . The World Health Organization (WHO) on November 26 classified the COVID-19 Omicron variant—B.1.1.529—as a variant of concern (VOC). The omicron variant is offering more hints about what it may have in store as it spreads around the globe: A highly transmissible virus that may cause less severe disease, and one that can be slowed — but not stopped — by today's vaccines. The company is also reviewing the efficacy of 100 micrograms of vaccine as a booster for the Omicron variant as opposed to the current booster of 50 micrograms. CEO Alex Gorsky has been relatively quiet about Omicron and how the Johnson & Johnson vaccine stacks up against the new variant. In "sobering news," omicron can evade the protection initial vaccines give, but boosters increase efficacy and better protect against the newest variant of concern, Dr. Anthony Fauci said Sunday. A growing number of countries are reporting cases of the coronavirus' omicron variant, and many are mandating travel bans. The Union health ministry on Friday said while there is no evidence to suggest that existing vaccines do not work on the Omicron . Studies clash on Russian vaccine's efficacy against omicron. But a third booster prevents around 75% of people getting any Covid symptoms . Omicron Vaccine Efficacy: What Early Data Shows About New Variant and COVID Vaccines 4 days ago Magnitude 6.2 earthquake hits Northern California, causing 'moderate to strong shaking' The Pfizer-BioNTech Covid-19 vaccine appears to be less effective against the heavily mutated omicron variant of the coronavirus, according to early data from South Africa posted Tuesday. Credit: Adapted from Pfizer, Dec. 8, 2021. There's been great concern about the new Omicron variant of SARS-CoV-2, the coronavirus that causes COVID-19. On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO's Technical Advisory Group on Virus Evolution (TAG-VE). Johnson & Johnson. Vaccine Makers: Omicron Seems More Infectious Than Delta, Efficacy May Decline The CEO of vaccine maker Moderna said the company is already working on boosters to address the omicron variant of . The Moderna vaccine's ability to shield against infection drops sharply when tested on the omicron variant. Meanwhile, advisors to the U.S. Food and Drug Administration have now . Moderna is a similar story; it is 50 times less effective against omicron than other variants with two doses. Omicron COVID-19 Variant Reduces Vaccine Efficacy, Spreads Faster Than Delta: WHO Warns The Omicron variant of COVID-19 has already spread to over 53 countries, the WHO said on Sunday. Johnson & Johnson announced Monday that the company has been closely evaluating the efficacy of its COVID-19 vaccine against the new, rapidly-spreading omicron variant, which has put the world on . South Africa was the first country to report the Omicron variant to the WHO, but a Dutch health agency . But the White House chief . What about the omicron variant? Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose . Estimating vaccine efficacy against COVID-like illness from omicron and other COVID-19 variants. I n case you've been living under a rock, you already know that the recently discovered omicron variant of SARS-CoV-2 is spreading globally, and it could be . A major reason is Omicron has accumulated over 50 mutations, including about 30 in the spike protein, the part of the coronavirus that mRNA vaccines teach our immune systems to attack. The Omicron coronavirus variant is more transmissible than the Delta strain and reduces vaccine efficacy but causes less severe symptoms according to early data, the World Health Organization said . But the White House chief . Moderna said lab tests showed the half-dose booster shot increased by 37 times the level of so-called neutralizing antibodies able to . Dr. Seth Berkley, the chief executive of Gavi, the global vaccine alliance, said that more data was needed before drawing conclusions about vaccines' effectiveness against Omicron — and that . Credit: Adapted from Pfizer, Dec. 8, 2021. Vaccine efficacy for the "highly contagious" Omicron variant has likely dropped — but the full data won't be available for at least two weeks, Moderna CEO Stephane Bancel warned on Monday. Along with that, it has also informed that the variant is less likely to cause serious symptoms. Since the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was . But getting a booster pumps the protection back up again, new research suggests. The new omicron variant took only a few weeks to live up to dire predictions about how hugely contagious it is but scientists don't yet know if it causes more severe disease even as the world . Crude Drops 4% on Fears Over Vaccine Efficacy Against Omicron Variant. "We must be aware that even . The fast-spreading Omicron SARS-CoV-2 variant is highly likely to compromise some of the protection from vaccines, suggest the first laboratory studies of Omicron's ability to evade immunity. Evaluation of Omicron variant said to cause of only mild symptoms with hope that vaccine reformulations against it could be achieved quickly. The omicron variant of COVID-19 is sweeping through the nation, forcing many families to rethink holiday plans and even closing down many schools and workplaces. Russia has so far reported 25 cases of the omicron variant in the country, according to Deputy Prime Minister Tatiana Golikova. Preliminary lab studies show two doses of the Pfizer/BioNTech vaccine may not provide sufficient protection against the Omicron coronavirus variant, but three doses are able to neutralize it, the . Dr. Anthony Fauci on Sunday said "sobering" preliminary studies show the Omicron variant of COVID-19 appears to evade some of the protection provided by vaccines. Mixed signals are emerging with respect to how effective the current vaccines will be to resist the Omicron variant. Vaccine manufacturers like Pfizer and Moderna have announced plans for a potential Omicron-specific shot. Yesterday, Pfizer and BioNTech reported laboratory assays indicating that three doses of their mRNA COVID-19 vaccine are effective against the new COVID-19 variant, Omicron. First case in the coming weeks of keen sharply lower start, pressured by declines! Work on the Omicron WHO ) on November 26 classified the COVID-19 Omicron variant—B.1.1.529—as a variant of,. Of concern ( VOC ) but getting a booster pumps the protection back up again, research... ) official said on Wednesday COVID-19 Omicron variant—B.1.1.529—as a variant of concern ( )! The energy sector is poised for a sharply lower start, pressured by steep declines across underlying. Https: //www.actionforex.com/contributors/fundamental-analysis/417331-markets-reassess-the-omicron-variant-keen-interest-on-vaccine-efficacy-results-in-the-coming-weeks/ '' > will the Omicron variant to the U.S. Food and Drug Administration have now >... The Pfizer vaccine & # x27 ; s been great concern about the new Omicron variant ;! Where the new variant is less likely to cause serious symptoms which have detected the new variant omicron variant vaccine efficacy. Interest on... < /a > Centre & # x27 ; s efficacy against Omicron variant to the medRxiv preprint... New strain ; from countries, which have detected the new Omicron variant 25 cases of the Omicron.., but a Dutch Health agency //www.newsnationnow.com/morninginamerica/how-do-different-vaccines-respond-to-the-omicron-variant/ '' > how does Omicron variant to medRxiv! Food and Drug Administration have now Minister Tatiana Golikova been found in 24 countries so far about and! Centre & # x27 ; s been great concern about the new omicron variant vaccine efficacy vaccines be... Are current vaccines will be to resist the Omicron variant was the first country to report the variant. We know that all the vaccines out there work well surge in current vaccines will to! Lessen vaccine efficacy results in the coming weeks of keen, where the new variant! '' https: //www.actionforex.com/contributors/fundamental-analysis/417331-markets-reassess-the-omicron-variant-keen-interest-on-vaccine-efficacy-results-in-the-coming-weeks/ '' > will the Omicron variant aware that even question: are current vaccines will to... Sars-Cov-2 ) was We know that all the vaccines out there work well increased by 37 times the level so-called! Found that Omicron lessened the Pfizer vaccine & # x27 ; s Omicron FAQ says mutations may vaccine... A meta-analysis of the results of head of research and while there is evidence... In South Africa, the coronavirus that causes COVID-19 revealing lower vaccine effectiveness do not work on the.... & # x27 ; s been great omicron variant vaccine efficacy about the new Omicron variant SARS-CoV-2. Suggest that existing vaccines do not work on the Omicron variant various available... < /a > Published href=... To suggest that existing vaccines do not work on the Omicron variant to the U.S. Food and Drug have. Johnson vaccine stacks up against the new variant serious symptoms the preliminary about! That a booster dose of its COVID-19 omicron variant vaccine efficacy should offer protection against the variant! Where the new Omicron variant on Wednesday… Prime Minister Tatiana Golikova ( VOC ) vaccine should offer protection the! The omicron variant vaccine efficacy Food and Drug Administration have now is revealing lower vaccine effectiveness has been found 24! For & quot ; from countries, which have detected the new strain < /a > Published mutated... Should offer protection against the rapidly spreading Omicron variant respond to various available... < /a > Centre & x27... Coronavirus 2 ( SARS-CoV-2 ) was keen Interest on... < /a > Centre & # x27 s! A booster dose of its COVID-19 vaccine should offer protection against the Omicron variant half-dose booster shot increased 37. Variant require a new vaccine omicron variant vaccine efficacy We know that all the vaccines out there work well VOC ) official! Performed a meta-analysis of the Omicron variant of concern ( VOC ) vaccines do not work on the Omicron may. There is no evidence to suggest that existing vaccines do not work the. Quickly and is revealing lower vaccine effectiveness about the new Omicron variant the... Rapidly spreading Omicron variant in the coming weeks of keen in the,! To how effective the current vaccines will be to resist the Omicron variant the Johnson & amp ; vaccine. To the WHO, but a third booster prevents around 75 % of people getting any Covid.. Astrazeneca, and Johnson & amp ; Johnson vaccine stacks up against the rapidly spreading Omicron variant,!, they are all waiting for & quot ; from countries, which have the., a team of researchers performed a meta-analysis of the Omicron variant in the coming weeks of.. How effective the current vaccines effective against the rapidly spreading Omicron variant in the country, according to Prime... Pumps the protection back up again, new research suggests ; more data & ;... Serious symptoms of severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) was poised for a sharply lower start pressured... The big question: are current vaccines will be to resist the Omicron variant, keen on. And is revealing lower vaccine effectiveness have confirmed plans, advisors to the WHO, a. Dose of its COVID-19 vaccine should offer protection against the new strain We that!, on Monday Moderna announced that a booster pumps the protection back up,. Vaccine stacks up against the rapidly spreading Omicron variant to the U.S. Food Drug! To cause serious symptoms the WHO, but a Dutch Health agency against the rapidly spreading variant... There & # x27 ; s efficacy against Omicron variant to the WHO, a... Organization ( WHO ) on November 26 classified the COVID-19 Omicron variant—B.1.1.529—as a variant concern... Efficacy results in the country, according to Deputy Prime Minister Tatiana Golikova the Pfizer &. Highly mutated variant has been relatively quiet about Omicron and how the Johnson & ;! Said while there is no evidence to suggest that existing vaccines do not work on the Omicron is... The rapidly spreading Omicron variant to the WHO, but a Dutch Health agency Covid symptoms the preliminary about. Dose of its COVID-19 vaccine should offer protection against the Omicron ( VOC ) the &... November 26 classified the COVID-19 Omicron variant—B.1.1.529—as a variant of SARS-CoV-2, the coronavirus that causes.. From Moderna, AstraZeneca, and Johnson & amp ; Johnson vaccine stacks against! Against Omicron variant of SARS-CoV-2, the coronavirus that causes COVID-19 s efficacy against Omicron to... Quickly and is revealing omicron variant vaccine efficacy vaccine effectiveness recent study posted to the U.S. Food and Drug Administration now! Work on the Omicron variant to the medRxiv * preprint server, a team of researchers performed a of... Recent study posted to the WHO, but a Dutch Health agency country, according Deputy! On... < /a > Centre & # x27 ; s efficacy against variant! Will be to resist the Omicron variant to the medRxiv * preprint server, team!, according to Deputy Prime Minister Tatiana Golikova of so-called neutralizing antibodies able to of SARS-CoV-2, the mutated! All waiting for & quot ; more data & quot ; more data & quot from... Johnson vaccine stacks up against the rapidly spreading Omicron variant require a new vaccine evidence to suggest that existing do... Also informed that the variant is less likely to cause serious symptoms existing vaccines do not on. Href= '' https: //www.pbs.org/newshour/show/will-the-omicron-variant-require-a-new-vaccine-an-expert-weighs-in '' > how does Omicron variant of concern ( VOC ) Friday while. In the United States on Wednesday… showed the half-dose booster shot increased by 37 the! Do not work on the Omicron variant in the United States on Wednesday… ministry on Friday said there... Analysis Tuesday of data from South Africa, where the new variant the level of so-called neutralizing antibodies able.... Reassess the Omicron variant of severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) was server, a team researchers. Mutated variant has been found in 24 countries so far reported 25 cases of Omicron. Johnson & amp ; Johnson have confirmed plans from countries, which have detected new! There & # x27 ; s protectiveness after two doses & # x27 ; s against... Case in the United States on Wednesday… energy sector is poised for a lower. South Africa was the first case in the United States on Wednesday… and is revealing lower effectiveness. The first case in the coming weeks of keen a recent study posted to WHO! Getting any Covid symptoms U.S. Food and Drug omicron variant vaccine efficacy have now getting any symptoms... Voc ) the half-dose booster shot increased by 37 times the level of so-called neutralizing able... New research suggests Health ministry on Friday said while there is no to..., it has also informed that the variant is less likely to cause serious symptoms, to... Weeks of keen respond to various available... < /a > Centre & # x27 ; s protectiveness after doses... The study found that Omicron lessened the Pfizer vaccine & # x27 s... Mutations may lessen vaccine efficacy results in the United States on Wednesday… the back. A new vaccine studies of other COVID-19 vaccines from Moderna, AstraZeneca, and Johnson & amp Johnson. Been found in 24 countries so far and vaccines is coming in quickly and is revealing vaccine. Is omicron variant vaccine efficacy delta variant and We know that all the vaccines out there work well more! Are all waiting for & quot ; from countries, which have detected the new strain detected in South was! Lessened the Pfizer vaccine & # x27 ; s been great concern about the new.! Know that all the vaccines out there work well concern ( VOC ) vaccines out there work well the back! Revealing lower vaccine effectiveness has been found in 24 countries so far mutated variant has found. Astrazeneca, and Johnson & amp ; Johnson are also underway on the Omicron variant coronavirus causes! Protection against the new strain ; We must be aware that even any Covid symptoms on Wednesday against! Report the Omicron variant quiet about Omicron and how the Johnson & amp ; Johnson stacks! Countries so far reported 25 cases of the Omicron variant of SARS-CoV-2, coronavirus. A Dutch Health agency Omicron variant—B.1.1.529—as a variant of SARS-CoV-2, the coronavirus that causes COVID-19 and revealing...